Sandu Pharmaceuticals has submitted a certificate from MUFG Intime India Pvt. Ltd., its Registrar and Share Transfer Agent, confirming that all securities received for dematerialisation during the quarter were processed—either accepted or rejected—and appropriately updated in the shareholder register. The dematerialised securities remain listed on the existing stock exchanges. Physical share certificates received were verified, mutilated, and cancelled as per procedure, with ownership transferred to depositories within required timelines. This ensures seamless electronic shareholding management, maintaining regulatory compliance and operational efficiency.